| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.007 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.099 | 0.007 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.007 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.091 | 0.008 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.092 | 0.009 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.092 | 0.009 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.009 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.009 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |